Literature DB >> 21892149

Believe it or not: how much can we rely on published data on potential drug targets?

Florian Prinz, Thomas Schlange, Khusru Asadullah.   

Abstract

Mesh：

Year:  2011        PMID： 21892149     DOI： 10.1038/nrd3439-c1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  What happens to the manuscripts that have not been accepted for publication in Occupational and Environmental Medicine?

Authors:  B Nemery
Journal:  Occup Environ Med       Date:  2001-09       Impact factor: 4.402

2.  What errors do peer reviewers detect, and does training improve their ability to detect them?

Authors:  Sara Schroter; Nick Black; Stephen Evans; Fiona Godlee; Lyda Osorio; Richard Smith
Journal:  J R Soc Med       Date:  2008-10       Impact factor: 5.344

3.  Fate of submitted manuscripts rejected from the American Journal of Neuroradiology: outcomes and commentary.

Authors:  R J McDonald; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

4.  Trial watch: Phase II failures: 2008-2010.

Authors:  John Arrowsmith
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

5.  Factors affecting reproducibility between genome-scale siRNA-based screens.

Authors:  Nicholas J Barrows; Caroline Le Sommer; Mariano A Garcia-Blanco; James L Pearson
Journal:  J Biomol Screen       Date:  2010-07-12

6.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613
  6 in total
  546 in total

1.  Irreproducible experimental results: causes, (mis)interpretations, and consequences.

Authors:  Joseph Loscalzo
Journal:  Circulation       Date:  2012-03-13       Impact factor: 29.690

2.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

3.  Drug targets slip-sliding away.

Authors: 
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

4.  ScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modeling.

Authors:  Jiyang Yu; Jose Silva; Andrea Califano
Journal:  Bioinformatics       Date:  2015-09-28       Impact factor: 6.937

5.  Tackling reproducibility in academic preclinical drug discovery.

Authors:  Stephen V Frye; Michelle R Arkin; Cheryl H Arrowsmith; P Jeffrey Conn; Marcie A Glicksman; Emily A Hull-Ryde; Barbara S Slusher
Journal:  Nat Rev Drug Discov       Date:  2015-09-21       Impact factor: 84.694

6.  Is There a Role for Publication Consultants and How Should Their Contribution be Recognized?

Authors:  Graham Kendall; Angelina Yee; Barry McCollum
Journal:  Sci Eng Ethics       Date:  2015-10-19       Impact factor: 3.525

7.  Robust research: Institutions must do their part for reproducibility.

Authors:  C Glenn Begley; Alastair M Buchan; Ulrich Dirnagl
Journal:  Nature       Date:  2015-09-03       Impact factor: 49.962

8.  Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research.

Authors:  Anthony Bowen; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

9.  From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.

Authors:  Daphne Day; Arta M Monjazeb; Elad Sharon; S Percy Ivy; Eric H Rubin; Gary L Rosner; Marcus O Butler
Journal:  Clin Cancer Res       Date:  2017-09-01       Impact factor: 12.531

10.  Assessing the validity and reproducibility of genome-scale predictions.

Authors:  Lauren A Sugden; Michael R Tackett; Yiannis A Savva; William A Thompson; Charles E Lawrence
Journal:  Bioinformatics       Date:  2013-09-17       Impact factor: 6.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.